Patients with haematological malignancies (HM) are at high risk of developing invasive
fungal disease (IFD) with high morbidity and attributable mortality. We reviewed data …

On the basis of improved overall survival, treatment guidelines strongly recommend
antifungal prophylaxis during remission induction chemotherapy for patients with acute …

Introduction Acute myeloid leukemia patients are at high risk for infections, which contribute
to increased mortality rates of up to 70%. The use of antimicrobial prophylaxis has been …

Abstract The Side Effects of Drugs Annuals is a series of volumes in which the adverse
effects of drugs and adverse reactions to them are surveyed. The series supplements the …

Invasive fungal diseases (IFDs) are one of the leading causes of death in lung transplant
recipients. This study aimed to compare the antifungal prophylactic effectiveness …

Invasive fungal infections (IFIs) are commonly observed in patients, who are at high risk of
severe infections during the neutropenic phase. The aim of this retrospective single-center …

Introduction This study characterized the multidose pharmacokinetic (PK) characteristics of
posaconazole tablets used as prophylactic antifungal therapy in Chinese patients with acute …

Background Invasive fungal infections commonly occur in acute myeloid and lymphoblastic
leukemia patients receiving chemotherapy. In these patients with acute leukemia …

Introduction The incidence of invasive fungal diseases (IFDs) has risen in hematologic
malignancy patients due to neutropenia. While posaconazole is recommended as the first …

A 20-year-old female with chronic granulomatous disease (CGD) presented with a 10-day
history of left hip pain and intermittent fever to an outpatient clinic in the Midwestern United …